GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aida Pharmaceuticals AIDA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2007

Revenue

$29.2m

FY2007FY2007

Net income

$2.7m

FY2007FY2007

Free cash flow

$4.8m

FY2007FY2007

Shareholders' equity

$13.3m

FY2007FY2007

Income statement

Fiscal years

FY2007
Revenue$29.2m
Gross profit$14.7m
Research and development$284,230
Operating income$5.4m
Net income$2.7m
Diluted earnings per share0.10

Balance sheet

At each fiscal year end

FY2007
Total assets$62.7m
Cash and short-term investments$19.0m
Total liabilities$41.5m
Debt$33.4m
Shareholders' equity$13.3m
Shares outstanding27m

Cash flow

Fiscal years

FY2007
Cash from operations$8.4m
Capital spending−$3.6m
Free cash flow$4.8m

Latest quarters

By quarter end

Sept 2008Jun 2008Mar 2008Dec 2007Sept 2007Jun 2007Mar 2007Dec 2006
Revenue$11.9m$10.9m$7.7m$10.5m$7.4m$6.4m$5.3m$10.0m
Gross profit$6.9m$6.2m$4.0m$5.7m$3.8m$2.8m$2.3m$5.6m
Operating income$2.5m$6.5m$684,202$3.3m$1.4m$811,708$27,312$1.6m
Net income$2.3m−$6.8m−$18,980$2.4m$519,061−$16,315−$160,000$126,911
Diluted earnings per share0.08-0.25-0.000.090.02-0.00-0.010.00
Cash from operations$2.0m$1.0m—$1.0m$4.0m−$1.0m$3.0m$2.0m
Capital spending−$2.0m——−$1.0m−$1.0m——−$1.0m
Free cash flow$0——$0$3.0m——$1.0m
Total assets$74.0m$66.6m$68.3m$62.7m$58.6m$57.8m$52.5m$53.8m
Cash and short-term investments$10.0m$5.9m$15.9m$19.0m$7.7m$9.6m$4.9m$6.5m
Debt$32.6m$29.4m$30.2m$31.7m$30.7m$32.1m$26.9m$27.6m
Shareholders' equity$9.2m$6.3m$13.2m$13.3m$11.1m$10.6m$10.4m$10.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue23.1%——
Operating income24.0%——
Net income18.8%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin51.4%58.0%——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return50%0%33%-76%42230%978%162%236294%986%0%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 6.4331-to-1 reverse split · 30 Nov 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.